Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations(4 sites)
South Korea
Korea University Anam Hospital, Seoul Seoul Asan Medical center, Seoul Seoul Asan Medical center, Seoul Seoul National University Hospital, Seoul